Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)
Condition(s):Essential ThrombocythemiaLast Updated:June 29, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Essential ThrombocythemiaLast Updated:June 29, 2023Completed
Condition(s):High Risk Polycythemia Vera; High Risk Essential ThrombocythemiaLast Updated:January 11, 2017Completed
Condition(s):Polycythemia Vera; Essential ThrombocythemiaLast Updated:April 20, 2020Terminated
Condition(s):Essential ThrombocythemiaLast Updated:June 14, 2021Completed
Condition(s):High Risk Polycythemia Vera; High Risk Essential ThrombocythemiaLast Updated:April 30, 2019Completed
Condition(s):Essential Thrombocythemia; Primary Myelofibrosis, Fibrotic Stage; Primary Myelofibrosis, Prefibrotic StageLast Updated:September 29, 2020Unknown status
Condition(s):Essential ThrombocythaemiaLast Updated:May 26, 2016Completed
Condition(s):Essential Thrombocythemia (ET)Last Updated:June 9, 2021Completed
Condition(s):Essential ThrombocythemiaLast Updated:November 30, 2023Active, not recruiting
Condition(s):Polycythemia Vera; Essential ThrombocythemiaLast Updated:September 12, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.